Table 4.

Treatment initiation or cessation in patients with organ damage*

	Damage to one organ system, receiving therapy for that organ		Damage to one organ system, not receiving therapy for that organ		Multiorgan damage, receiving therapy for those organs		Multiorgan damage, not receiving therapy for those organs
Starting treatment
Likelihood of starting treatment
Mean (median) score	8.1 (9)		7.0 (8)		7.1 (8)		6.3 (7)
Agreement	Do not start treatment	Start treatment	Do not start treatment	Start treatment	Do not start treatment	Start treatment	Do not start treatment	Start treatment
Mean (median) score		4.3 (4)		3.8 (4)		4.1 (4)	2.3 (2)
Score ≥4, n (%)		19 (90.5)		16 (76.2)		18 (85.7)	3 (14.3)
Stopping treatment
Likelihood of stopping treatment
Mean (median) score	2.8 (2)		3.9 (5)		3.9 (3)		4.8 (4)
Agreement	Do not stop treatment	Stop treatment	Do not stop treatment	Stop treatment	Do not stop treatment	Stop treatment	Do not stop treatment	Stop treatment
Mean (median) score	4.3 (4)		4.0 (4)		4.0 (4)		3.7 (4)
Score ≥4, n (%)	18 (85.7)		16 (76.2)		16 (76.2)		13 (61.9)

*For example, renal replacement therapy, kidney transplant or cardiac pacemaker. Where the median likelihood score awarded for starting or stopping treatment was ≥7.5 in round 1, panellists were asked in round 2 to rate their level of agreement with that course of action. Where the median likelihood score awarded was <7.5 in round 1, panellists were asked in round 2 to rate their level of agreement with not taking that course of action. Green shading: scenarios in which consensus was reached that either treatment should start or treatment should not be stopped. n=21.